repaglinide glp 1 Risk of hypoglycemia associated with combined with clopidogrel, a retrospective cohort study | Journal of Pharmaceutical Health Care and Sciences Repaglinide is used to lower blood sugar in patients with high blood sugar (diabetes). Repaglinide information sheet - Pitstop
Description
an effect that has led to FDA approval of several GLP-1 therapies specifically for obesity
Author contributions Z.Z., Y.Z
GLP-1 and Foot Health: Key Benefits &
For urgent situations where waiting could harm your health, you can request an expedited review with a decision within 72 hours
it is known that this risk increases with age and is more common in women (1.5 times that of men) (McClean et al., 2011
This approval is important because it recognizes that a GLP-1 receptor agonist can have a role beyond appetite and weight management for a specific liver-disease population
